Journal Mobile Options
Table of Contents
Vol. 131, No. 3, 2003
Issue release date: July 2003
Int Arch Allergy Immunol 2003;131:209–211

Oral Administration of Probiotic Escherichia coli after Birth Reduces Frequency of Allergies and Repeated Infections Later in Life (after 10 and 20 Years)

Lodinová-Zádníková R. · Cukrowska B. · Tlaskalova-Hogenova H.
aInstitute for Care of Mother and Child and bDepartment of Immunology and Gnotobiology, Institute of Microbiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic; cDepartment of Pathology, Children’s Memorial Health Institute, Warsaw, Poland

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background: The development of allergies is a complex in which both composition and influence of the intestinal flora play an important role. We observed in earlier studies that the presence of an orally administered probiotic Escherichia coli strain in the intestine stimulated both a serum and local antibody response, decreased the presence of pathogens, the number of infections and the need for antibiotics. Methods: The preventive effect of oral colonization after birth with a probiotic E. coli strain was assessed by evaluating the results of a questionnaire both 20 years (150 full-term infants) and 10 years (77 preterm infants) after colonization. Results: Differences in occurrence of allergies in colonized and control subjects were statistically significant both after 10 and 20 years (p < 0.01). Specific serum IgE antibodies confirmed the presence of allergies in 100% of 10-year-old and 91% of 20-year-old patients with clinical symptoms of allergy. Ten years after colonization, the occurrence of repeated infections was significantly lower in colonized subjects than it was in controls (p < 0.01); 20 years later, no differences were found in these groups. Conclusions: Intentional colonization of the intestine with E. coli after birth (offering the advantage of the first colonizer) was found to decrease the incidence of allergies and repeated infections in later life.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Lari AK, Gold F, Borderon JC, Laugier J, Lafont JP: Implantation and in vivo antagonistic effects of antibiotic-susceptible Escherichia coli strains administered to premature newborns. Biol Neonate 1990;58:73–78.
  2. Kalliomaki M, Salminen S, Arvilommi H, Koro P, Koskinen P, Isolauri E: Probiotics in primary prevention of atopic disease: A randomized placebo-controlled trial. Lancet 2001;357:1076–1079.
  3. Lodinova-Zadnikova R, Slavikova M, Tlaskalova-Hogenova H, Adlerberth I, Hanson LA, Wold A, Carlsson B, Svanborg C, Mellander L: The antibody response in breast-fed and non-breast-fed infants after artificial colonisation of the intestine with E. coli 083. Pediatr Res 1991;29:31–39.
  4. Lodinova-Zadnikova R, Tlaskalova H, Bartakova Z: The antibody response in infants after colonisation of the intestine with E. coli 083. Artificial colonisation used as prevention against nosocomial infections. Adv Exp Med Biol 1991;310:329–333.
  5. Tlaskalová-Hogenova H, Tuckova L, Lodinova-Zadnikova R, Stepankova R, Cukrowska B, Funda DP et al: Mucosal immunity: Its role in defense in allergy. Int Arch Allergy Immunol 2002;128:77–89.
  6. Cukrowska B, Lodinova-Zadnikova R, Enders C, Sonnenborn U, Schulz J, Tlaskalova-Hogenova H: Specific proliferative and antibody responses of premature infants to intestinal colonization with non-pathogenic probiotic E. coli strain Nissle 1917. Scand J Immunol 2002;55:204–209.

Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00